MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer

NCT00401492 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: gemcitabine prolonged continuous infusion
DRUG: cisplatin
DRUG: vinorelbine

Sponsor

National Cancer Institute, Naples